Clinical trials
Vulvar Neoplasms trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 10 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Recruiting | 12 |
| Unknown status | 12 |
| Active, not recruiting | 4 |
| Terminated | 3 |
| Withdrawn | 3 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 4 |
| Northwestern University | 3 |
| Ohio State University Comprehensive Cancer Center | 3 |
| Catholic University of the Sacred Heart | 2 |
| Karolinska Institutet | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Albert Einstein College of Medicine | 1 |
| Alpha Tau Medical LTD. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assiut University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vulvar Neoplasms | 67 |
| Uterine Cervical Neoplasms | 36 |
| Vaginal Neoplasms | 28 |
| Ovarian Neoplasms | 23 |
| Endometrial Neoplasms | 17 |
| Uterine Neoplasms | 12 |
| Anus Neoplasms | 8 |
| Breast Neoplasms | 6 |
| Penile Neoplasms | 5 |
| Carcinoma, Ovarian Epithelial | 4 |
Trials
Showing 76 to 67 of 67. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.